6-152122626-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.26204G>A​(p.Arg8735Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0361 in 1,614,050 control chromosomes in the GnomAD database, including 1,349 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 148 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1201 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0200
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0023429394).
BP6
Variant 6-152122626-C-T is Benign according to our data. Variant chr6-152122626-C-T is described in ClinVar as [Benign]. Clinvar id is 130434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152122626-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.063 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.26204G>A p.Arg8735Gln missense_variant 146/146 ENST00000367255.10 NP_892006.3
SYNE1NM_001347702.2 linkuse as main transcriptc.2738G>A p.Arg913Gln missense_variant 18/18 ENST00000354674.5 NP_001334631.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.26204G>A p.Arg8735Gln missense_variant 146/1461 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000354674.5 linkuse as main transcriptc.2738G>A p.Arg913Gln missense_variant 18/185 NM_001347702.2 ENSP00000346701.4 F8WAI0

Frequencies

GnomAD3 genomes
AF:
0.0432
AC:
6568
AN:
152122
Hom.:
149
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0457
Gnomad ASJ
AF:
0.0490
Gnomad EAS
AF:
0.0630
Gnomad SAS
AF:
0.0686
Gnomad FIN
AF:
0.0629
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0328
Gnomad OTH
AF:
0.0425
GnomAD3 exomes
AF:
0.0516
AC:
12978
AN:
251304
Hom.:
401
AF XY:
0.0498
AC XY:
6759
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.0515
Gnomad AMR exome
AF:
0.0809
Gnomad ASJ exome
AF:
0.0447
Gnomad EAS exome
AF:
0.0574
Gnomad SAS exome
AF:
0.0651
Gnomad FIN exome
AF:
0.0720
Gnomad NFE exome
AF:
0.0351
Gnomad OTH exome
AF:
0.0492
GnomAD4 exome
AF:
0.0353
AC:
51632
AN:
1461810
Hom.:
1201
Cov.:
33
AF XY:
0.0360
AC XY:
26146
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0473
Gnomad4 AMR exome
AF:
0.0761
Gnomad4 ASJ exome
AF:
0.0455
Gnomad4 EAS exome
AF:
0.0549
Gnomad4 SAS exome
AF:
0.0620
Gnomad4 FIN exome
AF:
0.0719
Gnomad4 NFE exome
AF:
0.0281
Gnomad4 OTH exome
AF:
0.0415
GnomAD4 genome
AF:
0.0432
AC:
6570
AN:
152240
Hom.:
148
Cov.:
33
AF XY:
0.0456
AC XY:
3393
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.0490
Gnomad4 AMR
AF:
0.0460
Gnomad4 ASJ
AF:
0.0490
Gnomad4 EAS
AF:
0.0626
Gnomad4 SAS
AF:
0.0691
Gnomad4 FIN
AF:
0.0629
Gnomad4 NFE
AF:
0.0328
Gnomad4 OTH
AF:
0.0412
Alfa
AF:
0.0336
Hom.:
189
Bravo
AF:
0.0419
TwinsUK
AF:
0.0245
AC:
91
ALSPAC
AF:
0.0231
AC:
89
ESP6500AA
AF:
0.0406
AC:
179
ESP6500EA
AF:
0.0335
AC:
288
ExAC
AF:
0.0509
AC:
6175
Asia WGS
AF:
0.0720
AC:
251
AN:
3478
EpiCase
AF:
0.0305
EpiControl
AF:
0.0306

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 26, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
8.4
DANN
Benign
0.90
DEOGEN2
Benign
0.17
T;.;.;T;T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.75
T;T;T;T;T
MetaRNN
Benign
0.0023
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.14
N;.;.;.;.
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.6
N;D;N;N;N
REVEL
Benign
0.022
Sift
Benign
0.22
T;D;T;T;T
Sift4G
Benign
0.48
T;T;T;T;T
Polyphen
0.0040
B;.;.;.;.
Vest4
0.043
MPC
0.15
ClinPred
0.0024
T
GERP RS
1.3
Varity_R
0.060
gMVP
0.28

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2295192; hg19: chr6-152443761; COSMIC: COSV55059389; COSMIC: COSV55059389; API